SIMPLEX TRADING, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 140 filers reported holding FATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
319
-96.6%
0.00%
Q2 2023$44
-24.1%
9,441
-8.7%
0.00%
Q1 2023$58
+286.7%
10,336
+587.2%
0.00%
Q4 2022$15
-100.0%
1,504
+10.2%
0.00%
Q3 2022$30,000
+650.0%
1,365
+689.0%
0.00%
Q2 2022$4,000
-99.0%
173
-98.3%
0.00%
Q1 2022$403,000
+1579.2%
10,417
+2345.3%
0.00%
Q4 2021$24,000
-96.9%
426
-97.8%
0.00%
-100.0%
Q3 2020$770,000
+2466.7%
19,284
+1121.3%
0.00%
Q4 2019$30,000
-81.4%
1,579
-84.8%
0.00%
Q3 2019$161,000
-25.8%
10,388
-3.2%
0.00%
-100.0%
Q2 2019$217,000
-32.8%
10,730
-41.7%
0.00%0.0%
Q1 2019$323,000
+201.9%
18,413
+119.4%
0.00%
Q4 2018$107,000
+10600.0%
8,394
+7263.2%
0.00%
Q3 2018$1,000
-99.3%
114
-99.1%
0.00%
-100.0%
Q2 2018$149,000
-48.1%
13,165
-55.3%
0.00%
-92.3%
Q1 2018$287,000
+1095.8%
29,462
+637.7%
0.01%
+1200.0%
Q4 2017$24,0003,994
+3740.4%
0.00%
Q3 2017$01040.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders